Shopping Cart
- Remove All
- Your shopping cart is currently empty
TRK-IN-21 (5n) is an orally active TRK inhibitor that acts on TRKAWT (IC50: 0.3 nM), TRKAG667C (IC50: 2.3 nM), TRKAF589L (IC50: 0.4 nM), and TRKAG595 (IC50: 0.5 nM). TRK-IN-21 can be used to study cancer.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $1,520 | 6-8 weeks | |
50 mg | $1,980 | 6-8 weeks | |
100 mg | $2,500 | 6-8 weeks |
Description | TRK-IN-21 (5n) is an orally active TRK inhibitor that acts on TRKAWT (IC50: 0.3 nM), TRKAG667C (IC50: 2.3 nM), TRKAF589L (IC50: 0.4 nM), and TRKAG595 (IC50: 0.5 nM). TRK-IN-21 can be used to study cancer. |
Molecular Weight | 424.45 |
Formula | C22H22F2N6O |
Cas No. | 2429985-55-5 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.